Biomarker blood tests early disease detection: 15,000-patient study (NCT04241796), 94.2% sensitivity. FDA Breakthrough Device, $949 cost.

Biomarker blood tests early disease detection: 15,000-patient study (NCT04241796), 94.2% sensitivity. FDA Breakthrough Device, $949 cost.
Explore the role of alzheimer genetics in understanding Alzheimer’s disease. Our Ultimate Guide provides expert insights and the latest research findings.